Chemixl Intermediates Profile
Key Indicators
- Authorised Capital ₹ 0.20 M
- Paid Up Capital ₹ 0.20 M
- Company Age 5 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth -87.42%
- Profit Growth -904.37%
- Ebitda -693.21%
- Net Worth -100.02%
- Total Assets -80.97%
About Chemixl Intermediates
Chemixl Intermediates Private Limited (CIPL) is a Private Limited Indian Non-Government Company incorporated in India on 13 March 2019 (Five years and ten months 29 days old ). Its registered office is in Valsad, Gujarat, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.20 M and a paid-up capital of Rs 0.20 M, as per Ministry of Corporate Affairs (MCA) records.
Shamim Ahmed, Hemant Madolli, and Iliyas Sayyad serve as directors at the Company.
Company Details
-
Location
Valsad, Gujarat, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24299GJ2019PTC107051
-
Company No.
107051
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
13 Mar 2019
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Ahmedabad
Industry
What products or services does Chemixl Intermediates Private Limited offer?
Chemixl Intermediates Private Limited offers a wide range of products and services, including Textile, Dyeing & Finishing Chemical, Textile Chemical, Industrial Chemicals & Supplies, Chemical Intermediates, Cosmetics, Hair & Beauty Products, Cosmetic Raw Material.
Who are the key members and board of directors at Chemixl Intermediates?
Board Members (3)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Shamim Ahmed | Director | 04-Oct-2022 | Current |
Hemant Madolli | Director | 04-Oct-2022 | Current |
Iliyas Sayyad | Director | 04-Oct-2022 | Current |
Financial Performance of Chemixl Intermediates.
Chemixl Intermediates Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 87.42% decrease. The company also saw a substantial fall in profitability, with a 904.37% decrease in profit. The company's net worth observed a substantial decline by a decrease of 100.02%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
|
||||||
Revenue from Operations |
|
||||||
Total Assets |
|
||||||
Profit or Loss |
|
||||||
Net Worth |
|
||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Chemixl Intermediates?
In 2022, Chemixl Intermediates had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Chemixl Intermediates?
Unlock and access historical data on people associated with Chemixl Intermediates, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Chemixl Intermediates, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Chemixl Intermediates's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.